Your browser doesn't support javascript.
loading
Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety.
Collier, Erin K; Seivright, Justine R; Shi, Vivian Y; Hsiao, Jennifer L.
Afiliação
  • Collier EK; David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Seivright JR; David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Shi VY; Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Hsiao JL; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Dermatol Ther ; 34(1): e14674, 2021 01.
Article em En | MEDLINE | ID: mdl-33320387
Hidradenitis suppurativa (HS) is a chronic inflammatory disease that disproportionately affects women of childbearing age. Pregnancy influences HS severity for many women, thus diligent continued management throughout pregnancy and postpartum may be required. Herein, we provide an updated review of pregnancy and lactation safety data for HS medications, including topical antiseptic washes, topical and systemic antibiotics, biologic and nonbiologic immunomodulators, immunosuppressants, adjunct medical therapies, and pain medications, to help guide risk-benefit discussions between providers and HS patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidradenite Supurativa Idioma: En Ano de publicação: 2021 Tipo de documento: Article